CCR5 and pancreatic neoplasm: Using human pancreatic adenocarcinoma and murine pancreatic tumor model, it has been found that CCR5 is highly expressed in TReg cells, while tumor cells produce elevated amount of CCL5, and disruption of CCR5/CCL5 chemokine axis blocks TReg cells migration and reduces tumor growth [34].